Re: NCDP - News & DD
Nicodrops, Inc. (PK: NCDP)
Many of our members have inquired about this home page stock pick that we chose back in December. Nicodrops had a strong move higher following our initial coverage and from announcements from the company that included the hiring of Joel Appel, a veteran salesman in the industry, and the placement of product at CVS Pharmacies. However, a lack of follow up store placements for product and a lawsuit filed by GlaxoSmithKline Consumer Healthcare put a damper on the share price since the beginning of the year.
Nicodrops continues to vigorously defend the lawsuit that begs the question; why would a giant like GlaxoSmithKline pick on this tiny pink sheet listed company? It appears obvious to us that the entrance of this newcomer onto this huge market is considered a credible threat. We will continue to track developments with the lawsuit as they are made available.
In the meantime, there is chatter on the message boards that Nicodrops may have landed some massive contracts. Although we cannot provide confirmation of this news now, The Green Baron Report believes that NCDP stock at this price is an absolute steal and represents a perfect entry point considering the risk verses reward. Currently NCDP trades at about .01 per share, below both our Stock to Watch price of .012 per share, and our home page profile price of .017 per share. A move back up to the .03 to .05 level would be expected should Nicodrops land a major deal.
Although we were hoping that news from Nicrodrops would have come by now, we remind our members of comments that we made in our update on January 8, 2005 when we stated, &#8220;Although The Green Baron Report remains very positive about the Nicodrops products and potential for strong sales, please understand that national distribution and huge sales do not occur overnight. It takes time to educate people through advertising and place the product where it can be purchased. Negotiations with key retailers and advertisers are ongoing. Although we anticipate more purchase orders with major retailers in the near term, we need to exhibit some patience while terms are negotiated and the Company&#8217;s business plans are implemented.&#8221;
Nicodrops, Inc., headquartered in La Mesa, CA, has developed the world's first drug free, non-nicotine product which is an aid to smokers wishing to give up their habit faster and at a lower cost than their major competitors without the adverse effects of nicotine. Nicodrops is an all-natural herb lozenge which helps to calm the nervous anxiety that is brought on by nicotine addiction. The company's lozenge products are based on patent protected proprietary technology which offers a safer alternative to all other nicotine based products in the marketplace today. More information can be found at the company&#8217;s website at www.nicodrops.com